发明名称 |
Mimetic peptides derived from collagen type IV and their use for treating angiogenesis- and lymphagiogenesis-dependent diseases |
摘要 |
Mimetic peptides having anti-angiogenic and anti-tumorigenic properties and methods of their use for treating cancer, ocular diseases, such as age-related macular degeneration, and other-angiogenesis-dependent diseases are disclosed. More particularly, active non-cysteine analogs (mimetics), which exhibit anti-angiogenic activity in endothelial cell proliferation, migration, adhesion, and tube formation assays, anti-migratory activity in human breast cancer cells in vitro, anti-angiogenic and anti-tumorigenic activity in vivo in breast cancer xenograft models, and age-related macular degeneration models are disclosed. The presently disclosed mimetic peptides also exhibit anti-lymphangiogenic and directly anti-tumorigenic properties. |
申请公布号 |
US9056923(B2) |
申请公布日期 |
2015.06.16 |
申请号 |
US201113992998 |
申请日期 |
2011.12.12 |
申请人 |
THE JOHNS HOPKINS UNIVERSITY |
发明人 |
Popel Aleksander S.;Rosca Elena V.;Koskimaki Jacob E.;Rivera Corban G.;Pandey Niranjan B.;Tamiz Amir P. |
分类号 |
C07K14/78;A61K38/39;A61P35/00;A61K38/00 |
主分类号 |
C07K14/78 |
代理机构 |
Ward and Smith, P.A. |
代理人 |
Ward and Smith, P.A. |
主权项 |
1. An isolated peptide comprising an amino acid sequence LRRFSTXPXXXXNINNVXNF (SEQ ID No:1), wherein X at position 7 is M, A, or G; X at position 9 is F, A, Y, or G; X at position 10 is M, A, G, dA, or Nle; X at position 11 is F, A, Y, G, or 4-ClPhe; X at position 12 and position 18 are G, V, T, I, L or AllyGly, and wherein the peptide exhibits anti-angiogenic, anti-vascular permeability, anti-tumorigenesis and/or anti-lymphangiogenic properties. |
地址 |
Baltimore MD US |